Description: Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Home Page: www.carmatsa.com
36, avenue de l'Europe
Vélizy-Villacoublay,
78140
France
Phone:
33 1 39 45 64 50
Officers
| Name | Title |
|---|---|
| Mr. Stephane Piat | CEO & Director |
| Ms. Pascale d'Arbonneau | CFO & Head of investor relations |
| Ms. Raouia Bouyanzer | Human Resources Director |
| Dr. Petrus Jansen | Chief Medical Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1166.974 |
| Price-to-Sales TTM: | 6.6349 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 162 |